Notably, hsa_circ_0041150 demonstrated superior diagnostic value for drug resistance compared to traditional lung cancer-related tumor markers such as CA125, CA211, and ProGRP in SCLC, albeit slightly weaker than NSE. The gene discussed is ENO2; the disease is lung carcinoma.